Meeting
2024 ASCO Annual Meeting
Increased risk for thyroid carcinoma in patients with Li-Fraumeni syndrome.
Authors
Anh N Le
Philadelphia College of Osteopathic Medicine, Philadelphia, PA
Anh N Le , Timothy Delaney , Tara McWilliams , Maliha N Tayeb , Caitlin Orr , Gregory Kelly , Ryan Hausler , Heena Desai , Hadley Barr , Sophie Cahill , Alison Schwartz Levine , Anne Naumer , Zubair W Baloch , Susan J Mandel , Luke Devon Maese , Wendy Kohlmann , Judy Ellen Garber , Jeffrey C Liu , Kara Noelle Maxwell
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Hereditary Cancer Syndromes
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 10612)
DOI
10.1200/JCO.2024.42.16_suppl.10612
Abstract #
10612
Poster Bd #
139
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Projection of cancer incidence and death to 2040 in the US: Impact of cancer screening and a changing demographic.
First Author: Lola Rahib
Poster
2016 ASCO Annual Meeting
Baseline cancer screening findings from the NCI Li-Fraumeni syndrome study.
First Author: Phuong L. Mai
Poster
2015 ASCO Annual Meeting
Evaluation of rapid whole-body magnetic resonance as screening strategy for early cancer detection in 57 Brazilian Li-Fraumeni syndrome patients.
First Author: Daniele Paixao
Poster
2011 ASCO Annual Meeting
Secondary leukemia 15 years or more after treatment for childhood cancer: A report from the Childhood Cancer Survivor Study.
First Author: K. Nottage